The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice
Open accessAbstract
Background and Purpose —Thrombosis superimposed on atherosclerosis causes approximately two thirds of all brain infarctions. We previously demonstrated that statins protect from cerebral ischemia by upregulation of endothelial type III nitric oxide synthase (eNOS), but the downstream mechanisms have not been determined. Therefore, we investigated whether antithrombotic effects contribute to stroke protection by statins. Methods —129/SV wild-type and eNOS knockout mice were treated with atorvastatin for 14 days (0.5, 1, and 10 mg/kg). eNOS mRNA from aortas and platelets was measured by reverse-transcriptase polymerase chain reaction. Platelet factor 4 (PF 4) and β-thromboglobulin (β-TG) in the plasma were quantified by ELISA. Transient cerebral ischemia was induced by filamentous occlusion of the middle cerebral artery followed by reperfusion. Results —Stroke volume after 1-hour middle cerebral artery occlusion/23-hour reperfusion was significantly reduced by 38% in atorvastatin-treated animals (10 mg/kg) compared with controls. Serum cholesterol levels were not affected by the treatment. eNOS mRNA was significantly upregulated in a dose-dependent manner in aortas and in thrombocytes of statin-treated mice compared with controls. Moreover, indices of platelet activation in vivo, ie, plasma levels of PF 4 and β-TG, were dose-dependently downregulated in the treatment group. Surprisingly, atorvastatin-treatment did not influence PF 4 and β-TG levels in eNOS knockout mice. Conclusions —The synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin upregulates eNOS in thrombocytes, decreases platelet activation in vivo, and protects from cerebral ischemia in normocholesterolemic mice. Antithrombotic and stroke-protective effects of statins are mediated in part by eNOS upregulation. Our results suggest that statins may provide a novel prophylactic treatment strategy independent of serum cholesterol levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Self-citationUpregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Self-citationTuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski, M. W., Palmer, R. M., & Moncada, S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5193 · Cited by 1,208
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035
Self-citationEndres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 966
Self-citationAspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease
Pitt, B., Waters, D., Brown, W. V., van Boven, A. J., Schwartz, L., Title, L. M., Eisenberg, D., Shurzinske, L., & McCormick, L. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410202 · Cited by 946
(1995) · The Lancet · doi:10.1016/s0140-6736(95)92836-7 · Cited by 856
Drug Treatment of Lipid Disorders
Knopp, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410707 · Cited by 845
Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J., Sánchez-Pascuala, R., Hernández, G., Díaz, C., & Lamas, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1500 · Cited by 763
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
Huang, Z., Huang, P. L., Ma, J., Meng, W., Ayata, C., Fishman, M. C., & Moskowitz, M. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00023 · Cited by 718
Self-citationStatins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
Crouse, J. R., Byington, R. P., Bond, M. G., Espefand, M. A., Craven, T. E., Sprinkle, J. W., McGovern, M. E., & Furberg, C. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80580-3 · Cited by 609
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Kaplan, K., & Owen, J. (1981) · Blood · doi:10.1182/blood.v57.2.199.199 · Cited by 518
Lacoste, L., Lam, J. Y. T., Hung, J., Letchacovski, G., Solymoss, C. B., & Waters, D. (1995) · Circulation · doi:10.1161/01.cir.92.11.3172 · Cited by 441
Nitric oxide released from activated platelets inhibits platelet recruitment.
Freedman, J. E., Loscalzo, J., Barnard, M. R., Alpert, C., Keaney, J. F., & Michelson, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119540 · Cited by 389
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Vaughan, C. J., & Delanty, N. (1999) · Stroke · doi:10.1161/01.str.30.9.1969 · Cited by 386
Laufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
Self-citationEssig, M., Nguyen, G., Prié, D., Escoubet, B., Sraer, J.-D., & Friedlander, G. (1998) · Circulation Research · doi:10.1161/01.res.83.7.683 · Cited by 316
Morikawa, E., Moskowitz, M. A., Huang, Z., Yoshida, T., Irikura, K., & Dalkara, T. (1994) · Stroke · doi:10.1161/01.str.25.2.429 · Cited by 229
Deficient Platelet-Derived Nitric Oxide and Enhanced Hemostasis in Mice Lacking the NOSIII Gene
Freedman, J. E., Sauter, R., Battinelli, E. M., Ault, K., Knowles, C., Huang, P. L., & Loscalzo, J. (1999) · Circulation Research · doi:10.1161/01.res.84.12.1416 · Cited by 219
Self-citationAtkins, D., Psaty, B. M., Koepsell, T. D., Longstreth, W. T., & Larson, E. B. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00008 · Cited by 212
Direct Electrochemical Measurement of Nitric Oxide Released from Human Platelets
Malinski, T., Radomski, M. W., Taha, Z., & Moncada, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1914 · Cited by 196
Expression of constitutive endothelial nitric oxide synthase in human blood platelets
Sase, K., & Michel, T. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02191-k · Cited by 193
Chen, L. Y., Mehta, P., & Mehta, J. L. (1996) · Circulation · doi:10.1161/01.cir.93.9.1740 · Cited by 180
Impaired Platelet Production of Nitric Oxide Predicts Presence of Acute Coronary Syndromes
Freedman, J. E., Ting, B., Hankin, B., Loscalzo, J., Keaney, J. F., & Vita, J. A. (1998) · Circulation · doi:10.1161/01.cir.98.15.1481 · Cited by 172
Neuroprotective effects of gelsolin during murine stroke
Endres, M., Fink, K., Zhu, J., Stagliano, N. E., Bondada, V., Geddes, J. W., Azuma, T., Mattson, M. P., Kwiatkowski, D. J., & Moskowitz, M. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4953 · Cited by 158
Self-citationLipids and Stroke: A Paradox Resolved
Hachinski, V. C., Graffagnino, C., Beaudry, M., Bernier, G., Buck, C., Donner, A., Spence, J. D., Doig, G., & Wolfe, B. M. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040031011 · Cited by 156
Vascular Effects of Statins in Stroke
Delanty, N., & Vaughan, C. J. (1997) · Stroke · doi:10.1161/01.str.28.11.2315 · Cited by 151
Yamada, M., Huang, Z., Dalkara, T., Endres, M., Laufs, U., Waeber, C., Huang, P. L., Liao, J. K., & Moskowitz, M. A. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00008 · Cited by 146
Self-citationWollny, T., Aiello, L., Tommaso, D. D., Bellavia, V., Rotilio, D., Donati, M. B., de Gaetano, G., & Iacoviello, L. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702586 · Cited by 136
Natural Statins and Stroke Risk
Furberg, C. D. (1999) · Circulation · doi:10.1161/01.cir.99.2.185 · Cited by 134
Szczeklik, A., Musiał, J., Undas, A., Gajewski, P., Góra, P., Swadźba, J., & Jankowski, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00023-6 · Cited by 128
HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
Hess, D. C., Demchuk, A. M., Brass, L. M., & Yatsu, F. M. (2000) · Neurology · doi:10.1212/wnl.54.4.790 · Cited by 128
Endothelium and acute coronary syndromes
Liao, J. K. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1799 · Cited by 122
Molecular biology of atherosclerosis
Libby, P., Sukhova, G. K., Lee, R. T., & Liao, J. K. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00238-6 · Cited by 121
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data.
Crouse, J., Byington, R., & Furberg, C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00014-8 · Cited by 117
Aviram, M., Hussein, O., Rosenblat, M., Schlezinger, S., Hayek, T., & Keidar, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199801000-00006 · Cited by 117
Atorvastatin Increases ecNOS Levels in Human Platelets of Hyperlipidemic Subjects
Tannous, M., Cheung, R. M. C., Vignini, A., & Mutus, B. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614841 · Cited by 72
Effect of Nitric Oxide Synthase Inhibition on Bleeding Time in Humans
Simon, D. I., Stamler, J. S., Loh, E., Loscalzo, J., Francis, S. A., & Creager, M. A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00022 · Cited by 68
Lewis, R. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)80039-x · Cited by 31
Current controversies in bone marrow transplantation
Treleaven, J. G. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702594 · Cited by 27
Antithrombotic therapies for stroke prevention
Solomon, D. H., & Hart, R. G. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199402000-00009 · Cited by 18
Statins for prevention of stroke
Blauw, G. J., Lagaay, A. M., & Westendorp, R. G. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85049-6 · Cited by 17
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Self-citationPleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Self-citationNitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567
Athyros, V. G., Papageorgiou, A. A., Mercouris, B. R., Athyrou, V. V., Symeonidis, A. N., Basayannis, E. O., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000787 · Cited by 533
Metadata
- Authors
- Laufs, U., Gertz, K., Huang, P., Nickenig, G., Böhm, M., Dirnagl, U., & Endres, M.
- Venue
- Stroke
- Published
- 2000-10
- Volume
- 31
- Issue
- 10
- Pages
- 2442-2449
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2112728084
- Cited by
- 390
- References
- 53
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.